Researchers study design for protective HIV vaccine

Researchers study design for protective HIV vaccine. Courtesy of sciencedaily.com
Researchers study design for protective HIV vaccine. - Courtesy of sciencedaily.com
0Comments

A Ph.D. student named Jinal Bhiman, who attends the University of Witwatersrand, recently wrote an article about the designs of protective HIV vaccines and their importance in the fight against HIV.

A person with an HIV infection has a changing viral swarm that can generate antibodies fully capable of eliminating HIV strains around the world. This has implications for the future designs of HIV vaccines meant to protect people from contracting HIV.

Experts maintain that a vaccine will be the best way to stop the HIV pandemic. Unfortunately generating broadly neutralizing antibodies to fight HIV has been a significant challenge; this is because certain people with HIV infections are naturally capable of generating antibodies.

Scientists have studied these rare people to better understand how the antibodies can be generated to fight the virus.

“The study also showed how these early antibodies matured to become broadly neutralizing,” the researchers said. “As the HIV-swarm struggled to evade these potent early antibodies, it toggled through many mutations in its surface protein. This exposed the maturing antibodies to a diverse range of viruses within this single infected woman. Antibodies exposed to this high level of viral diversity in turn mutated to be able to tolerate variation, thus acquiring the ability to neutralize diverse global viruses.”

Further details are available in Nature Medicine, a prestigious journal, under the title of “Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies.”



Related

dummy-img

380 people die in New York state from heart disease in week ending March 12

There were 380 deaths with heart disease listed as the underlying cause reported in New York state during the week ending March 12, a 3.3 percent decrease from the previous week.

dummy-img

70 people die in New York state with COVID-19 listed as the underlying cause in week ending March 12

There were 70 deaths with COVID-19 listed as the underlying cause reported in New York state during the week ending March 12, a 20.5 percent decrease from the previous week.

dummy-img

29 people die in New York state from kidney disease in week ending March 12

There were 29 deaths with nephritis, nephrotic syndrome and nephrosis listed as the underlying cause reported in New York state during the week ending March 12, no changes from the previous week.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from Vaccine News Daily.